LC/MS/MS Rapid Toxicology Screening System Ver.3
Others | 2021 | ShimadzuInstrumentation
This note describes a rapid LC/MS/MS screening workflow for toxicology applications, combining simplified sample preparation with a comprehensive spectral library. By streamlining analysis of more than 230 commonly encountered drugs and metabolites, the system addresses the need for fast, reliable screening in forensic, clinical and research laboratories.
The primary goal of this work is to deliver a turnkey solution for high-throughput toxicology screening using Shimadzu’s LCMS-8060NX platform. Key objectives include:
The workflow integrates a micro-volume QuEChERS-based sample preparation and a synchronized survey-scan MRM method.
The system successfully detected and differentiated 231 compounds within a single run. Semi-quantitative values were obtained using preconfigured calibration curves with isotope-labeled internal standards. Library search scores provided reliable spectral matches, while maintaining throughput. The combination of retention time information and spectral similarity enhanced compound identification confidence. Quantitative performance may vary by instrument condition, so users are encouraged to verify results with appropriate calibration standards.
This turnkey solution offers laboratories:
Advancements may include expansion of the compound library, integration of high-resolution MS for untargeted screening, automation of sample preparation and incorporation of machine-learning algorithms for spectral deconvolution and anomaly detection.
Shimadzu’s Rapid Toxicology Screening System Ver. 3 combines streamlined QuEChERS pretreatment, optimized LC/MS/MS conditions and a robust spectral library to deliver efficient, semi-quantitative screening of 231 compounds. This approach meets the growing demand for fast and accurate toxicology analysis in various laboratory settings.
Software, LC/MS, LC/MS/MS, LC/QQQ
IndustriesForensics
ManufacturerShimadzu
Summary
Importance of the Topic
This note describes a rapid LC/MS/MS screening workflow for toxicology applications, combining simplified sample preparation with a comprehensive spectral library. By streamlining analysis of more than 230 commonly encountered drugs and metabolites, the system addresses the need for fast, reliable screening in forensic, clinical and research laboratories.
Study Objectives and Overview
The primary goal of this work is to deliver a turnkey solution for high-throughput toxicology screening using Shimadzu’s LCMS-8060NX platform. Key objectives include:
- Minimizing method development time by providing optimized chromatographic and MS parameters.
- Enabling rapid data acquisition with analysis times below 15 minutes.
- Incorporating a library of 231 target compounds covering drugs of abuse, psychotropics and common pharmaceuticals.
- Facilitating semi-quantitative reporting through internal-standard-based calibration curves.
Methods and Instrumentation
The workflow integrates a micro-volume QuEChERS-based sample preparation and a synchronized survey-scan MRM method.
- Sample type: Biological fluids pretreated with the micro-volume QuEChERS kit (extraction, centrifugation, transfer of supernatant).
- Chromatography: Rapid gradient separation on Shimadzu LC system, under 15 minutes per run.
- Mass spectrometry: Shimadzu LCMS-8060NX triple quadrupole with optimized MRM transitions, survey scan thresholds and collision energies.
- Data processing: LabSolutions Insight Library Screening Ver. 3.8SP1 for quantitative results, library matching, chromatograms, MS/MS spectra and structure display.
Main Results and Discussion
The system successfully detected and differentiated 231 compounds within a single run. Semi-quantitative values were obtained using preconfigured calibration curves with isotope-labeled internal standards. Library search scores provided reliable spectral matches, while maintaining throughput. The combination of retention time information and spectral similarity enhanced compound identification confidence. Quantitative performance may vary by instrument condition, so users are encouraged to verify results with appropriate calibration standards.
Benefits and Practical Applications
This turnkey solution offers laboratories:
- Reduced method development overhead.
- High sample throughput for routine toxicology screening.
- Comprehensive coverage of drugs and metabolites relevant to forensic and clinical cases.
- Integrated data review with spectral library match and semi-quantitation.
Future Trends and Applications
Advancements may include expansion of the compound library, integration of high-resolution MS for untargeted screening, automation of sample preparation and incorporation of machine-learning algorithms for spectral deconvolution and anomaly detection.
Conclusion
Shimadzu’s Rapid Toxicology Screening System Ver. 3 combines streamlined QuEChERS pretreatment, optimized LC/MS/MS conditions and a robust spectral library to deliver efficient, semi-quantitative screening of 231 compounds. This approach meets the growing demand for fast and accurate toxicology analysis in various laboratory settings.
Used Instrumentation
- Shimadzu LCMS-8060NX triple quadrupole mass spectrometer.
- LabSolutions LCMS Ver. 5.109 or later and LabSolutions Insight Ver. 3.8SP1 software.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Screening and Semi-Quantitation by LC/MS/MS in Whole Blood Using Rapid Tox Screening
2021|Shimadzu|Applications
Application News High Performance Liquid Chromatograph Mass Spectrometer : LCMSTM-8045/LCMS-8050/LCMS-8060NX Screening and Semi-Quantitation by LC/MS/MS in Whole Blood Using Rapid Tox Screening Waters B1, Arao Y, Imoto E 1 Department of Forensic Medicine, Faculty of Medicine, Fukuoka University User Benefits…
Key words
biperiden, biperidenautopsy, autopsyblood, bloodsss, ssshaloperidol, haloperidolscreening, screeningsemi, semirapid, rapidtoxicology, toxicologyzopiclone, zopiclonewhole, wholemrm, mrmquantitative, quantitativeautopsied, autopsiedmethod
Rapid screening and semi-quantitative analysis for forensic drugs in blood using liquid chromatography triple quadrupole mass spectrometry
2013|Shimadzu|Posters
PO-CON1302E Rapid screening and semi-quantitative analysis for forensic drugs in blood using liquid chromatography triple quadrupole mass spectrometry ASMS 2013 WP-121 Thomas Hayes1, Keiko Kudo2, Toshikazu Minohata3, Kiyotaka Usui4, Noriaki Shima5, Munehiro Katagi5, Hitoshi Tsuchihashi6, Koichi Suzuki6, Ichiro Hirano3, Noriaki…
Key words
neg, negdrugs, drugsforensic, forensicquantitative, quantitativetriple, tripleblood, bloodscreening, screeningquadrupole, quadrupolesemi, semithc, thcrapid, rapidflunitrazepam, flunitrazepambromovalerylurea, bromovalerylureaquazepam, quazepamalprazolam
Rapid screening method covers common 161 forensic drugs by ultra-high speed LC/MS/MS with synchronized survey scanning
2015|Shimadzu|Posters
PO-CON1530E Rapid screening method covers common 161 forensic drugs by ultra-high speed LC/MS/MS with synchronized survey scanning ASMS 2015 ThP-177 Toshikazu Minohata 1; Keiko Kudo 2; Noriaki Shima 3; Munehiro Katagi 3;Kiyotaka Usui 4; Hitoshi Tsuchihashi 5; Koichi Suzuki 5;…
Key words
area, areasynchronized, synchronizedneg, negmuscle, musclesurvey, surveyscanning, scanningultra, ultraspeed, speedwhole, wholeliver, liverblood, bloodheart, heartstd, stdalpha, alphabromovalerylurea
Screening analysis for drugs of abuse by LC-MS/MS enables fast polarity switching MRM triggered product ion scanning on the fly
2012|Shimadzu|Posters
Screening analysis for drugs of abuse by LC-MS/MS enables fast polarity switching MRM triggered product ion scanning on the fly ASMS 2012 MP24-591 Keiko Kudo1; Toshikazu Minohata2; Junko Iida2; Hitoshi Tsuchihashi3; Kiochi Suzuki3; Kei Zaitsu4; Noriaki Shima4; Munehiro Katagi4; Noriaki…
Key words
neg, negdrugs, drugstriggered, triggeredscanning, scanningfly, flypolarity, polarityabuse, abuseproduct, productmrm, mrmswitching, switchingion, ionfast, fasthypnotic, hypnoticallylisopropylacetylurea, allylisopropylacetylurealoflazepate